Pharmaceutical advanced formulations

Pharmaceutical advanced formulations

InnoStudio’s ContiFlowTM Technology Platform, renowned for its precision, converts active pharmaceutical ingredients into advanced formulations. The sub-micron-sized matrix particles it
generates are the key to significantly improved bioavailability and other advantageous properties of the drugs. This platform ensures the faster achievement of advanced formulation targets
with unparalleled precision, instilling confidence in its reliability.

Active pharmaceutical ingredients
  • Increase in apparent solubility to enhance the availability of the compounds
  • Improved bioavailability to enhance efficacy
  • Substantial reduction in effective dosage to mitigate serious side effects and adverse events
  • Removal of food-effect
  • Substantially shortened time to reach maximum plasma concentration (tmax) and increased maximum plasma concentration (Cmax)
  • Alteration in the route of administration.

Service

Innostudio offers various services, including proof-of-concept formulation studies, process scale-up, and pilot-scale manufacturing for its partners.
For expert assistance with pharmaceutical formulation, please don’t hesitate to contact us.

Service

InnoStudio offers licenses of the ContiFlowTM Technology Platform to our partners, allowing them to scale-up the manufacturing process to pilot-size production or beyond.

Feel free to contact us to learn more about our ContiFlowTM Technology Platform licenses.